Your browser doesn't support javascript.
loading
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Vergori, Alessandra; Cozzi Lepri, Alessandro; Cicalini, Stefania; Matusali, Giulia; Bordoni, Veronica; Lanini, Simone; Meschi, Silvia; Iannazzo, Roberta; Mazzotta, Valentina; Colavita, Francesca; Mastrorosa, Ilaria; Cimini, Eleonora; Mariotti, Davide; De Pascale, Lydia; Marani, Alessandra; Gallì, Paola; Garbuglia, AnnaRosa; Castilletti, Concetta; Puro, Vincenzo; Agrati, Chiara; Girardi, Enrico; Vaia, Francesco; Antinori, Andrea.
Afiliación
  • Vergori A; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy. alessandra.vergori@inmi.it.
  • Cozzi Lepri A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK.
  • Cicalini S; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Matusali G; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Bordoni V; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Lanini S; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Meschi S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Iannazzo R; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Mazzotta V; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Colavita F; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Mastrorosa I; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Cimini E; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Mariotti D; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • De Pascale L; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Marani A; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Gallì P; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Garbuglia A; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Castilletti C; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Puro V; Risk Management Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Agrati C; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Girardi E; Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Vaia F; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Antinori A; HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
Nat Commun ; 13(1): 4922, 2022 08 22.
Article en En | MEDLINE | ID: mdl-35995780
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Italia